Ashiq Mubarack

Stock Analyst at Citigroup

(1.38)

# 2,543

Out of 4,433 analysts

2

Total ratings

50%

Success rate

12.04%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$2.83	+182.69%	1	Dec 15, 2023
	MRSN Mersana Therapeutics	Upgrades: Buy	$1 → $5	$2.73	+83.15%	1	Dec 4, 2023

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $2.83

Upside: +182.69%

Mersana Therapeutics

Dec 4, 2023

Upgrades: Buy

Price Target: $1 → $5

Current: $2.73

Upside: +83.15%